These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2283560)

  • 41. Separation of tissue and serum acid phosphatase isoenzymes by ion-exchange column chromatography.
    Mercer DW
    Clin Chem; 1977; 23(4):653-8. PubMed ID: 844161
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of methotrexate-monoclonal anti-prostatic acid phosphatase antibody conjugate on human prostate tumor.
    Deguchi T; Chu TM; Leong SS; Horoszewicz JS; Lee CL
    Cancer Res; 1986 Aug; 46(8):3751-5. PubMed ID: 3731053
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Isolation and biochemical characteristics of a molecular form of epididymal acid phosphatase of boar seminal plasma.
    Wysocki P; Strzezek J
    Theriogenology; 2006 Dec; 66(9):2152-9. PubMed ID: 16919323
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of acid phosphatase isoenzymes of human seminal fluid, prostate, and leukocytes.
    Lam WK; Yam LT; Wilbur HJ; Taft E; Li CY
    Clin Chem; 1979 Jul; 25(7):1285-9. PubMed ID: 455650
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization and purification of acid phosphatase from ancient human bone.
    Demir Y; Yildirim S; Alayli A; Demir N
    Prep Biochem Biotechnol; 2003 Nov; 33(4):311-20. PubMed ID: 14606688
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prostatic acid phosphatase assay with self-indicating substrate 2,6-dichloro-4-acetylphenyl phosphate.
    Osawa S; Iida S; Yonemitsu H; Kuroiwa K; Katayama K; Nagasawa T
    Clin Chem; 1995 Feb; 41(2):200-3. PubMed ID: 7874772
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A tartrate-resistant acid phosphatase from Gaucher spleen. Purification and properties.
    Robinson DB; Glew RH
    J Biol Chem; 1980 Jun; 255(12):5864-70. PubMed ID: 7380839
    [No Abstract]   [Full Text] [Related]  

  • 48. Comparison of the antigenic peptides between human prostatic and lysosomal acid phosphatases.
    Lee HS; Lee CL; Li SS
    J Protein Chem; 1991 Apr; 10(2):253-6. PubMed ID: 1718311
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Purification of prostatic acid phosphatase and prostate specific antigen from human seminal plasma].
    Aoki T; Tanaka T; Kataoka S; Horikawa H; Watabe H
    Hokkaido Igaku Zasshi; 1988 Nov; 63(6):963-70. PubMed ID: 2470661
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel prostate acid phosphatase-based peptide vaccination strategy induces antigen-specific T-cell responses and limits tumour growth in mice.
    Saif JM; Vadakekolathu J; Rane SS; McDonald D; Ahmad M; Mathieu M; Pockley AG; Durrant L; Metheringham R; Rees RC; McArdle SE
    Eur J Immunol; 2014 Apr; 44(4):994-1004. PubMed ID: 24338683
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structural and kinetic properties of a novel purple acid phosphatase from phosphate-starved tomato (Lycopersicon esculentum) cell cultures.
    Bozzo GG; Raghothama KG; Plaxton WC
    Biochem J; 2004 Jan; 377(Pt 2):419-28. PubMed ID: 14521509
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tartrate-resistant purple acid phosphatase is synthesized as a latent proenzyme and activated by cysteine proteinases.
    Ljusberg J; Ek-Rylander B; Andersson G
    Biochem J; 1999 Oct; 343 Pt 1(Pt 1):63-9. PubMed ID: 10493912
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The cytochemical demonstration of prostatic acid phosphatase using a new substrate, phosphorylcholine.
    Serrano JA; Shannon WA; Sternberger NJ; Wasserkrug HL; Serrano AA; Seligman AM
    J Histochem Cytochem; 1976 Oct; 24(10):1046-56. PubMed ID: 977936
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fractionation and purification of prostatic acid phosphatase.
    Pais VM; Mangold AW; Mahoney SA
    Invest Urol; 1974 Jul; 12(1):13-6. PubMed ID: 4135033
    [No Abstract]   [Full Text] [Related]  

  • 55. A comparative study of the use of monoclonal antibodies using three different immunohistochemical methods: an evaluation of monoclonal and polyclonal antibodies against human prostatic acid phosphatase.
    Naritoku WY; Taylor CR
    J Histochem Cytochem; 1982 Mar; 30(3):253-60. PubMed ID: 7037942
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of an immunoassay for human serum osteoclastic tartrate-resistant acid phosphatase.
    Kraenzlin ME; Lau KH; Liang L; Freeman TK; Singer FR; Stepan J; Baylink DJ
    J Clin Endocrinol Metab; 1990 Aug; 71(2):442-51. PubMed ID: 2380339
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of conjugation on the biodistribution of 111In-labelled anti-PAP and anti-PSA monoclonal antibodies examined in nude mice with PC-82 human tumor xenografts.
    Perälä-Heape M; Vihko P; Pelkonen I; Laine A; Vihko R
    In Vivo; 1991; 5(2):159-65. PubMed ID: 1722716
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunohistological approaches to human prostatic epithelial cells.
    Choe BK; Pontes JE; Lillehoj HS; Rose NR
    Prostate; 1980; 1(4):383-98. PubMed ID: 7024956
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design of spindle poisons activated specifically by prostatic acid phosphatase (PAP) and new methods for PAP cytochemistry.
    Seligman AM; Sternberger NJ; Paul BD; Friedman AE; Shannon WA; Wasserkrug HL; Plapinger RE; Lynm D
    Cancer Chemother Rep; 1975; 59(1):233-42. PubMed ID: 805658
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Generation and characterization of putative monoclonal and polyclonal antibodies against tartrate-resistant acid phosphatase.
    Nelson PN; Chambers T
    Hybridoma; 1995 Feb; 14(1):91-4. PubMed ID: 7768539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.